Drupal.behaviors.print = function(context) {window.print();window.close();}>

Med BioGene Accepts Amended Offer from Precision Therapeutics

March 28, 2011

Med BioGene Accepts Amended Offer from Precision Therapeutics

Precision Therapeutics made an improved offer, matching the upfront payment offered by Signal Genetics to license the LungExpress Dx technology.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.

Related Stories